Franchi Jean M.

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-02-20	2025-02-18	Gemini Therapeutics Inc (GMTX)	S Sale	3,136 -4.3% 54.58 USD 171,163	3,136 -4.3%	54.58	USD 171,163
2023-05-18	2023-05-16	Replimune Group Inc (REPL)	S Sale	11,351 -8.1% 18.05 USD 204,886	11,351 -8.1%	18.05	USD 204,886
2022-05-18	2022-05-16	Replimune Group Inc (REPL)	S Sale	3,436 -3.5% 14.59 USD 50,131	3,436 -3.5%	14.59	USD 50,131
2021-01-15	2021-01-14	Replimune Group Inc (REPL)	PS Planned sale	600 -100.0% 44.00 USD 26,400	600 -100.0%	44.00	USD 26,400
2021-01-15	2021-01-14	Replimune Group Inc (REPL)	PS Planned sale	14,300 -96.0% 44.55 USD 637,065	14,300 -96.0%	44.55	USD 637,065
2021-01-15	2021-01-13	Replimune Group Inc (REPL)	PS Planned sale	100 -100.0% 44.19 USD 4,419	100 -100.0%	44.19	USD 4,419
2020-12-16	2020-12-14	Replimune Group Inc (REPL)	PS Planned sale	389 -100.0% 42.09 USD 16,373	389 -100.0%	42.09	USD 16,373
2020-12-16	2020-12-14	Replimune Group Inc (REPL)	PS Planned sale	6,755 -94.6% 42.86 USD 289,519	6,755 -94.6%	42.86	USD 289,519
2020-12-16	2020-12-14	Replimune Group Inc (REPL)	PS Planned sale	17,856 -71.4% 43.70 USD 780,307	17,856 -71.4%	43.70	USD 780,307